おすすめの製品
フォーム
liquid
品質水準
比活性
≥5 units/mg protein
メーカー/製品名
Calbiochem®
保管条件
OK to freeze
avoid repeated freeze/thaw cycles
輸送温度
wet ice
保管温度
−20°C
詳細
Native plasmin from human plasma. Catalyzes the hydrolysis of peptides, arginine and lysine esters and converts fibrin into soluble products.
Native plasmin from human plasma. Catalyzes the hydrolysis of peptides, arginine and lysine esters, and converts fibrin into soluble products.
包装
Please refer to vial label for lot-specific concentration.
警告
Toxicity: Standard Handling (A)
単位の定義
One unit is defined as the amount of enzyme that will hydrolyze 1.0 µmol of N-tosyl-Gly-Pro-Lys-pNA per min at 25°C, pH 7.8.
物理的形状
In 100 mM sodium phosphate, 1 mM 6-aminohexanoic acid, 25% glycerol, pH 7.3.
調製ノート
Prepared from plasma that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.
再構成
Following initial thaw, aliquot and freeze (-20°C).
その他情報
Federici, A.B., et al. 1993. Blood 81, 720.
Hoffmann, J.J., and Janssen, W.C. 1992. Thromb. Res. 67, 711.
Hoffmann, J.J., and Janssen, W.C. 1992. Thromb. Res. 67, 711.
法的情報
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
免責事項
RESEARCH USE ONLY. This product is regulated in France when intended to be used for scientific purposes, including for import and export activities (Article L 1211-1 paragraph 2 of the Public Health Code). The purchaser (i.e. enduser) is required to obtain an import authorization from the France Ministry of Research referred in the Article L1245-5-1 II. of Public Health Code. By ordering this product, you are confirming that you have obtained the proper import authorization.
保管分類コード
10 - Combustible liquids
WGK
WGK 2
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
Jan Code
527621-U:
527621-10U:
試験成績書(COA)
製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。
J J Hoffmann et al.
Thrombosis research, 67(6), 711-719 (1992-09-15)
The mechanisms by which thrombolytic agents affect platelet function are not yet elucidated. The aim of the present study was to investigate the effects of plasmin, generated by thrombolytic agents in plasma, on platelet glycoproteins (GP) Ib and IIb/IIIa. Platelet-rich
A B Federici et al.
Blood, 81(3), 720-725 (1993-02-01)
The behavior of plasma von Willebrand factor (vWF) in patients with acute leukemia (n = 5), decompensated cirrhosis (n = 10), and acute pancreatitis (n = 5) was investigated to evaluate whether the systemic proteolytic states associated with these diseases
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら(テクニカルサービス)